Investigations of p53 deficiency in pancreatic cancer have shown increased YAP signaling that indicates the mutual exclusivity of PTPN14 and TP53 mutations and the requirement of PTPN14 for p53-mediated tumor suppression in human cancers (41). This evidence concerns the gene PTPN14 and cancer.